Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • Index
    • Overview and Device Description
    • Information provided by the Manufacturer
    • Design and Manufacturing Information
    • GSPR
    • Benefit-Risk Analysis and Risk Management
    • Product Verification and Validation
      • Software
      • Artificial Intelligence
      • Cybersecurity
      • Usability and Human Factors Engineering
      • Clinical
        • Evaluation
        • Investigation
          • 🗄 Drafts
          • ALADIN 2026
            • Certificación de Cobertura de Seguro de Responsabilidad Civil
            • Civil Liability Insurance Coverage Certification
            • R-015-005 Investigator's Brochure Legit.Health_acne
          • ADS TLD DAO 2025
          • AIHS4 2025
          • BI 2024
          • COVIDX EVCDAO 2022
          • DAO Derivación O 2022
          • DAO Derivación PH 2022
          • IDEI 2023
          • MC EVCDAO 2019
          • PH 2024
          • SAN 2024
        • R-TF-015-008 Clinical development plan
      • Commissioning
    • Post-Market Surveillance
  • Legit.Health Plus Version 1.1.0.1
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Grants
  • Pricing
  • Public tenders
  • Legit.Health Plus Version 1.1.0.0
  • Product Verification and Validation
  • Clinical
  • Investigation
  • ALADIN 2026
  • Civil Liability Insurance Coverage Certification

Civil Liability Insurance Coverage Certification

Project Details​

Project Title: Pilot study for the clinical validation of a medical device for the automatic assessment of severity and remote monitoring of patients with acne.

Project Code: Legit.Health_acne

Sponsor: AI Labs Group S.L.


Insurance Coverage Statement​

This document officially certifies that the above-referenced project is fully covered without exclusion under the Civil Liability Insurance Policy held by Legit.Health for the year 2025.

Policy Information​

  • Policy Holder: Legit.Health
  • Policy Number: [To be completed with specific policy number]
  • Policy Period: 2025
  • Coverage Limits: [To be completed with specific coverage amounts per occurrence]
  • Policy Document: Available at /apps/qms/docs/licenses-and-accreditations/civil-liability-insurance/2025.pdf

Coverage Scope​

The project entitled "Pilot study for the clinical validation of a medical device for the automatic assessment of severity and remote monitoring of patients with acne" (Code: Legit.Health_acne) is fully covered without limitation under the terms and conditions of the Civil Liability Insurance Policy for 2025 and 2026, in compliance with RD 1090/2015 and applicable regulatory requirements for clinical device investigations.

This coverage includes:

  • Professional liability coverage for the development and validation of the medical device
  • Coverage for clinical investigation activities and device validation studies
  • Protection for sponsor organization (AI Labs Group S.L.) and Legit.Health during the pilot study execution
  • Coverage for potential liabilities arising from the clinical validation activities
  • Coverage is not subject to any exclusions or restrictions related to the nature of this clinical device validation study

Exclusions and Limitations​

This project is NOT subject to coverage limitations, exclusions, or restrictions related to its classification as a clinical device validation study. The policy provides comprehensive liability protection for all activities conducted under this project code.

Project Duration​

This insurance coverage is effective from April 18, 2025 through April 18, 2026, covering the entire duration of the pilot study as conducted under the aforementioned project code and title. This certification is valid as of the date issued and remains effective throughout the policy period, subject to the terms of the insurance policy.


Acknowledgment​

By this certification, it is acknowledged that:

  1. The project is registered with Legit.Health quality management system
  2. All project activities comply with applicable standards and regulatory requirements, including RD 1090/2015
  3. The project is fully insured under the 2025 Civil Liability Insurance Policy without exclusions
  4. Any Ethics Committee inquiries regarding insurance coverage for this project should reference this certification document and the policy document available in the organization's documentation system
  5. This project maintains continuous insurance coverage for the entire 2025 calendar year

Authorized Certification​

Certified by:

  • Department: Legit.Health Quality Assurance or Risk Management
  • Date of Certification: December 9, 2025
  • Authorized Representative Signature: ********___********
  • Name and Title: ********___********

For insurance coverage verification or emergency inquiries, contact: [Quality Assurance or Risk Management department contact information]


Document Information​

  • Document Type: Insurance Coverage Certification
  • Date of Certification: December 9, 2025
  • Document Validity: Valid through April 18, 2026 (policy period)
  • Organization: Legit.Health
  • Classification: Internal Documentation
  • Regulatory Compliance: RD 1090/2015 (Clinical Investigation Regulations)

For inquiries regarding this certification or insurance coverage details, please contact the Legit.Health Quality Assurance or Risk Management department.

Previous
Certificación de Cobertura de Seguro de Responsabilidad Civil
Next
R-015-005 Investigator's Brochure Legit.Health_acne
  • Project Details
  • Insurance Coverage Statement
    • Policy Information
    • Coverage Scope
      • Exclusions and Limitations
    • Project Duration
  • Acknowledgment
  • Authorized Certification
  • Document Information
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)